185 related articles for article (PubMed ID: 26109559)
21. Mutant B-RAF signaling and cyclin D1 regulate Cks1/S-phase kinase-associated protein 2-mediated degradation of p27Kip1 in human melanoma cells.
Bhatt KV; Hu R; Spofford LS; Aplin AE
Oncogene; 2007 Feb; 26(7):1056-66. PubMed ID: 16924241
[TBL] [Abstract][Full Text] [Related]
22. [Expression of nuclear export factor CRM1 and p27 in glioma].
Wang DL; Wang YC; Lu P; E Q; Shi GS
Zhonghua Bing Li Xue Za Zhi; 2008 Jul; 37(7):454-7. PubMed ID: 19035116
[TBL] [Abstract][Full Text] [Related]
23. 111In-labeled immunoconjugates (ICs) bispecific for the epidermal growth factor receptor (EGFR) and cyclin-dependent kinase inhibitor, p27Kip1.
Cornelissen B; Kersemans V; McLarty K; Tran L; Reilly RM
Cancer Biother Radiopharm; 2009 Apr; 24(2):163-73. PubMed ID: 19409037
[TBL] [Abstract][Full Text] [Related]
24. Expression of CRM1 in human gliomas and its significance in p27 expression and clinical prognosis.
Shen A; Wang Y; Zhao Y; Zou L; Sun L; Cheng C
Neurosurgery; 2009 Jul; 65(1):153-9; discussion 159-60. PubMed ID: 19574837
[TBL] [Abstract][Full Text] [Related]
25. Knockdown of CRM1 inhibits the nuclear export of p27(Kip1) phosphorylated at serine 10 and plays a role in the pathogenesis of epithelial ovarian cancer.
Wang Y; Wang Y; Xiang J; Ji F; Deng Y; Tang C; Yang S; Xi Q; Liu R; Di W
Cancer Lett; 2014 Feb; 343(1):6-13. PubMed ID: 24018641
[TBL] [Abstract][Full Text] [Related]
26. A clinical, biologic and mechanistic analysis of the role of ZNF692 in cervical cancer.
Zhu B; Pan Y; Zheng X; Zhang Q; Wu Y; Luo J; Li Q; Lu E; Xu L; Jin G; Ren B
Gynecol Oncol; 2019 Feb; 152(2):396-407. PubMed ID: 30466806
[TBL] [Abstract][Full Text] [Related]
27. PCBP1 depletion promotes tumorigenesis through attenuation of p27
Shi H; Li H; Yuan R; Guan W; Zhang X; Zhang S; Zhang W; Tong F; Li L; Song Z; Wang C; Yang S; Wang H
J Exp Clin Cancer Res; 2018 Aug; 37(1):187. PubMed ID: 30086790
[TBL] [Abstract][Full Text] [Related]
28. The inhibition of activated hepatic stellate cells proliferation by arctigenin through G0/G1 phase cell cycle arrest: persistent p27(Kip1) induction by interfering with PI3K/Akt/FOXO3a signaling pathway.
Li A; Wang J; Wu M; Zhang X; Zhang H
Eur J Pharmacol; 2015 Jan; 747():71-87. PubMed ID: 25498792
[TBL] [Abstract][Full Text] [Related]
29. Expression and subcellular localization of the cyclin-dependent kinase inhibitor p27(Kip1) in epithelial ovarian cancer.
Hurteau JA; Allison BM; Brutkiewicz SA; Goebl MG; Heilman DK; Bigsby RM; Harrington MA
Gynecol Oncol; 2001 Nov; 83(2):292-8. PubMed ID: 11606087
[TBL] [Abstract][Full Text] [Related]
30. miR-222 confers the resistance of breast cancer cells to Adriamycin through suppression of p27(kip1) expression.
Wang DD; Li J; Sha HH; Chen X; Yang SJ; Shen HY; Zhong SL; Zhao JH; Tang JH
Gene; 2016 Sep; 590(1):44-50. PubMed ID: 27282281
[TBL] [Abstract][Full Text] [Related]
31. The prognostic impact of cyclin dependent kinase inhibitors p21WAF1, p27Kip1, and p16INK4/MTS1 in adenocarcinomas of the uterine cervix: an immunohistochemical evaluation of expression patterns in population-based material from 142 patients with international federation of gynecology and obstetrics stage I and II adenocarcinoma.
Alfsen GC; Reed W; Sandstad B; Kristensen GB; Abeler VM
Cancer; 2003 Nov; 98(9):1880-9. PubMed ID: 14584070
[TBL] [Abstract][Full Text] [Related]
32. p27Kip1 repression of ErbB2-induced mammary tumor growth in transgenic mice involves Skp2 and Wnt/beta-catenin signaling.
Hulit J; Lee RJ; Li Z; Wang C; Katiyar S; Yang J; Quong AA; Wu K; Albanese C; Russell R; Di Vizio D; Koff A; Thummala S; Zhang H; Harrell J; Sun H; Muller WJ; Inghirami G; Lisanti MP; Pestell RG
Cancer Res; 2006 Sep; 66(17):8529-41. PubMed ID: 16951165
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of TRIP6 promotes tumor proliferation and reverses cell adhesion-mediated drug resistance (CAM-DR) via regulating nuclear p27(Kip1) expression in non-Hodgkin's lymphoma.
Miao X; Xu X; Wu Y; Zhu X; Chen X; Li C; Lu X; Chen Y; Liu Y; Huang J; Wang Y; He S
Tumour Biol; 2016 Jan; 37(1):1369-78. PubMed ID: 26298725
[TBL] [Abstract][Full Text] [Related]
34. Blockade of protein geranylgeranylation inhibits Cdk2-dependent p27Kip1 phosphorylation on Thr187 and accumulates p27Kip1 in the nucleus: implications for breast cancer therapy.
Kazi A; Carie A; Blaskovich MA; Bucher C; Thai V; Moulder S; Peng H; Carrico D; Pusateri E; Pledger WJ; Berndt N; Hamilton A; Sebti SM
Mol Cell Biol; 2009 Apr; 29(8):2254-63. PubMed ID: 19204084
[TBL] [Abstract][Full Text] [Related]
35. miR-222 induces Adriamycin resistance in breast cancer through PTEN/Akt/p27
Wang DD; Yang SJ; Chen X; Shen HY; Luo LJ; Zhang XH; Zhong SL; Zhao JH; Tang JH
Tumour Biol; 2016 Nov; 37(11):15315-15324. PubMed ID: 27699665
[TBL] [Abstract][Full Text] [Related]
36. Keratin 17 is a negative prognostic biomarker in high-grade endometrial carcinomas.
Bai JDK; Babu S; Roa-Peña L; Hou W; Akalin A; Escobar-Hoyos LF; Shroyer KR
Hum Pathol; 2019 Dec; 94():40-50. PubMed ID: 31655172
[TBL] [Abstract][Full Text] [Related]
37. Immunohistochemically detected expression of p27(Kip1) and Skp2 predicts survival in patients with intrahepatic cholangiocarcinomas.
Hashimoto N; Yachida S; Okano K; Wakabayashi H; Imaida K; Kurokohchi K; Masaki T; Kinoshita H; Tominaga M; Ajiki T; Ku Y; Okabayashi T; Hanazaki K; Hiroi M; Izumi S; Mano S; Okada S; Karasawa Y; Maeba T; Suzuki Y
Ann Surg Oncol; 2009 Feb; 16(2):395-403. PubMed ID: 19034576
[TBL] [Abstract][Full Text] [Related]
38. Msi1 promotes tumor growth and cell proliferation by targeting cell cycle checkpoint proteins p21, p27 and p53 in cervical carcinomas.
Liu X; Yang WT; Zheng PS
Oncotarget; 2014 Nov; 5(21):10870-85. PubMed ID: 25362645
[TBL] [Abstract][Full Text] [Related]
39. The prognostic of p27(kip1) in ovarian cancer: a meta-analysis.
Lu M; Wang Y; Xu F; Xiang J; Chen D
Arch Gynecol Obstet; 2016 Jan; 293(1):169-176. PubMed ID: 26198169
[TBL] [Abstract][Full Text] [Related]
40. Reduced expression of the RNA-binding protein HuD in pancreatic neuroendocrine tumors correlates with low p27
Kim C; Jeong DE; Heo S; Ji E; Rho JG; Jung M; Ahn S; Kim YJ; Kim YS; Nam SW; Kulkarni RN; Lee KB; Lee EK; Kim W
J Pathol; 2018 Oct; 246(2):231-243. PubMed ID: 30014466
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
